Williams & Novak, LLC
- SEC CIK
- 0001998419
- Latest filing
- Jul 8, 2026
TSHA holding history
Taysha Gene Therapies, Inc. in every 13F filed by Williams & Novak, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TSHA overviewAll 13F holders of TSHAFull Q2 2026 holdings
- Shares (Q2 2026)
- 45,000
- Value
- $306.4K
- % of portfolio
- 0.2%
- Quarters held
- 11
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 45,000 | $306.4K | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2026 | 45,000 | $193.9K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 45,000 | $247.5K | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2025 | 45,000 | $147.2K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 45,000 | $104.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 45,000 | $56.9K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 45,000 | $77.8K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 45,000 | $90.5K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 45,000 | $100.8K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 45,000 | $79.7K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 45,000 | $79.7K | 0.1% | – | No prior filing | Holders |